Erik A. Ranheim

Also affiliated with Wisconsin Division of Public Health

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2”.

Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3294

N/A

0.874DataRank · unranked

23 citations

Igor B. Kuznetsov, Erik A. Ranheim, Jun S. Wei, Sivasish Sindiri, Berkley E. Gryder +13 more

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1345

N/A

0.851DataRank · unranked

22 citations

Fangxin Hong, Thomas M. Habermann, Ranjana H. Advani, Randy D. Gascoyne, Thomas E. Witzig +11 more

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection

PLOS Pathogens(2020)10.1371/journal.ppat.1008365

N/A

0.564DataRank · unranked

42 citations

Shane M. Huebner, Makoto Ohashi, Jillian A. Bristol, Bayleigh E. Benner, Elizabeth A. Barlow +11 more

Tcof1 haploinsufficiency promotes early T cell precursor-like leukemia in NrasQ61R/+ mice

Leukemia(2022)10.1038/s41375-022-01510-7

N/A

0.241DataRank · unranked

4 citations

Remington Finn, Xin Gao, Lin Li, Alexander S. Hebert, Erik A. Ranheim +10 more

Gata2 −77 enhancer regulates adult hematopoietic stem cell survival

Leukemia(2020)10.1038/s41375-020-0942-6

N/A

0DataRank · unranked

6 citations

Yuan-I Chang, Guangyao Kong, Erik A. Ranheim, Yun Zhou, Kirby D. Johnson +4 more

Expression of Nras Q61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice

Blood(2020)10.1182/blood.2020007156

N/A

0DataRank · unranked

44 citations

Adhithi Rajagopalan, Evan Flietner, Grant Yun, Marta Chesi, Quinlan Furumo +20 more

Gata2 +9.5 enhancer regulates adult hematopoietic stem cell self-renewal and T-cell development

Blood Advances(2021)10.1182/bloodadvances.2021004311

N/A

0DataRank · unranked

17 citations

Yun Zhou, Yuan‐I Chang, Guangyao Kong, Erik A. Ranheim, Kirby D. Johnson +4 more

Phase I/II trial of intratumoral administration of hu14.18-IL2, with local radiation, nivolumab, and ipilimumab in subjects with advanced melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps9591

N/A

0DataRank · unranked

2 citations

Zachary S. Morris, Jacquelyn A. Hank, Erik A. Ranheim, Cindy Zuleger, Kimberly A. McDowell +13 more

862 Administration of intratumoral hu14.18-IL2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0862

N/A

0DataRank · unranked

0 citations

Cindy Zuleger, Erik A. Ranheim, Oyewale Shiyanbola, Andrew T. Kosharek, Paul M. Sondel +12 more

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice

PLoS Pathogens(2024)10.1371/journal.ppat.1012132

N/A

0DataRank · unranked

9 citations

Scott E. Nelson, Makoto Ohashi, Alejandro Casco, Mitchell Hayes, Erik A. Ranheim +6 more

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma

Melanoma Research(2024)10.1097/cmr.0000000000000975

N/A

0DataRank · unranked

7 citations

Cindy Zuleger, Erik A. Ranheim, Oyewale Shiyanbola, Paul M. Sondel, Zachary S. Morris +9 more

Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition

Frontiers in Oncology(2020)10.3389/fonc.2020.585151

N/A

0DataRank · unranked

5 citations

Yoon Jung Choi, Ho Sun Jung, Aditi Majumder, Sujal I. Shah, Igor I. Slukvin +2 more

An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model

Journal of Virology(2020)10.1128/jvi.02168-19

N/A

0DataRank · unranked

11 citations

Makoto Ohashi, Reza Djavadian, Mark R. Eichelberg, Mitchell Hayes, Nicholas A. Zumwalde +8 more

Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories

The Journal of Experimental Medicine(2020)10.1084/jem.20191526

N/A

0DataRank · unranked

44 citations

Daniel Conn, Evgenia Shishkova, Koichi R. Katsumura, Peng Liu, Siqi Shen +10 more

EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice

PLoS Pathogens(2020)10.1371/journal.ppat.1008590

N/A

0DataRank · unranked

30 citations

James C. Romero-Masters, Shane M. Huebner, Makoto Ohashi, Mitchell Hayes, Jillian A. Bristol +8 more